Plasma Ephrin-A1 level in a cohort of diabetic retinopathy patients

Abstract Background To determine plasma ephrin-A1 and VEGF165 levels in a cohort of diabetic retinopathy patients. Methods Plasma ephrin-A1 and VEGF165 levels in fifty-five subjects including 19 individuals without diabetes (non-DM), 16 patients with diabetes (DM) but without diabetic retinopathy, a...

Full description

Bibliographic Details
Main Authors: Danna Mao, Ying Hu, Qi Bao, Kewei Wu, Yaoding Zheng, Yukun Yang, Bo Lei, Ying Jiang
Format: Article
Language:English
Published: BMC 2020-08-01
Series:BMC Ophthalmology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12886-020-01580-0
_version_ 1818306218884595712
author Danna Mao
Ying Hu
Qi Bao
Kewei Wu
Yaoding Zheng
Yukun Yang
Bo Lei
Ying Jiang
author_facet Danna Mao
Ying Hu
Qi Bao
Kewei Wu
Yaoding Zheng
Yukun Yang
Bo Lei
Ying Jiang
author_sort Danna Mao
collection DOAJ
description Abstract Background To determine plasma ephrin-A1 and VEGF165 levels in a cohort of diabetic retinopathy patients. Methods Plasma ephrin-A1 and VEGF165 levels in fifty-five subjects including 19 individuals without diabetes (non-DM), 16 patients with diabetes (DM) but without diabetic retinopathy, and 20 patients with diabetic retinopathy (DR), were determined by ELISA. Serum creatinine, total cholesterol, fasting blood glucose and HbA1c were also measured. One-way ANOVA, Kruskal-Wallis Test, Mann-Whitney U Test corrected by Bonferroni, Pearson Correlation Analysis and Spearman Correlation Coefficient Analysis were used for data analysis. Results Ephrin-A1 expression could be detected in human plasma with an average of 1.52 ± 0.43 (mean ± SEM) ng/ml. In DR subjects, the plasma ephrin-A1concentration was 3.63 ± 4.63 ng/ml, which was significantly higher than that of the other two groups (non-DM: 0.27 ± 0.13 ng/ml, DM: 0.35 ± 0.34 ng/ml). The expression of VEGF165 in human plasma was 34.00 ± 42.55 pg/ml, with no statistical difference among the three groups. There was no correlation between ephrin-A1 and VEGF165 in human plasma, but there was a correlation between plasma ephrin-A1 and duration of diabetes. Conclusions Plasma ephrin-A1 was highly expressed in patients with diabetic retinopathy, and there was no difference of plasma VEGF165 expression in patients with diabetic retinopathy compared to the other two groups, suggesting that changes of plasma ephrin-A1 may be a more sensitive biomarker than plasma VEGF165 in detecting diabetic retinopathy.
first_indexed 2024-12-13T06:39:00Z
format Article
id doaj.art-c2e6f3b6d3394580aa522dbc99f38fce
institution Directory Open Access Journal
issn 1471-2415
language English
last_indexed 2024-12-13T06:39:00Z
publishDate 2020-08-01
publisher BMC
record_format Article
series BMC Ophthalmology
spelling doaj.art-c2e6f3b6d3394580aa522dbc99f38fce2022-12-21T23:56:28ZengBMCBMC Ophthalmology1471-24152020-08-012011510.1186/s12886-020-01580-0Plasma Ephrin-A1 level in a cohort of diabetic retinopathy patientsDanna Mao0Ying Hu1Qi Bao2Kewei Wu3Yaoding Zheng4Yukun Yang5Bo Lei6Ying Jiang7Department of Ophthalmology, Medical community of Fenghua Hospital of Traditional Chinese MedicineDepartment of Ophthalmology, Medical community of Fenghua Hospital of Traditional Chinese MedicineDepartment of Clinical Laboratory, Medical community of Fenghua Hospital of Traditional Chinese MedicineDepartment of Ophthalmology, Medical community of Fenghua Hospital of Traditional Chinese MedicineDepartment of Ophthalmology, Medical community of Fenghua Hospital of Traditional Chinese MedicineDepartment of Ophthalmology, Medical community of Fenghua Hospital of Traditional Chinese MedicinePeople’s Hospital of Zhengzhou University, Henan Provincial People’s Hospital, Henan Eye Institute, Henan Eye InstituteDepartment of Ophthalmology, Medical community of Fenghua Hospital of Traditional Chinese MedicineAbstract Background To determine plasma ephrin-A1 and VEGF165 levels in a cohort of diabetic retinopathy patients. Methods Plasma ephrin-A1 and VEGF165 levels in fifty-five subjects including 19 individuals without diabetes (non-DM), 16 patients with diabetes (DM) but without diabetic retinopathy, and 20 patients with diabetic retinopathy (DR), were determined by ELISA. Serum creatinine, total cholesterol, fasting blood glucose and HbA1c were also measured. One-way ANOVA, Kruskal-Wallis Test, Mann-Whitney U Test corrected by Bonferroni, Pearson Correlation Analysis and Spearman Correlation Coefficient Analysis were used for data analysis. Results Ephrin-A1 expression could be detected in human plasma with an average of 1.52 ± 0.43 (mean ± SEM) ng/ml. In DR subjects, the plasma ephrin-A1concentration was 3.63 ± 4.63 ng/ml, which was significantly higher than that of the other two groups (non-DM: 0.27 ± 0.13 ng/ml, DM: 0.35 ± 0.34 ng/ml). The expression of VEGF165 in human plasma was 34.00 ± 42.55 pg/ml, with no statistical difference among the three groups. There was no correlation between ephrin-A1 and VEGF165 in human plasma, but there was a correlation between plasma ephrin-A1 and duration of diabetes. Conclusions Plasma ephrin-A1 was highly expressed in patients with diabetic retinopathy, and there was no difference of plasma VEGF165 expression in patients with diabetic retinopathy compared to the other two groups, suggesting that changes of plasma ephrin-A1 may be a more sensitive biomarker than plasma VEGF165 in detecting diabetic retinopathy.http://link.springer.com/article/10.1186/s12886-020-01580-0Ephrin-A1VEGF165PlasmaDiabetic retinopathyELISA
spellingShingle Danna Mao
Ying Hu
Qi Bao
Kewei Wu
Yaoding Zheng
Yukun Yang
Bo Lei
Ying Jiang
Plasma Ephrin-A1 level in a cohort of diabetic retinopathy patients
BMC Ophthalmology
Ephrin-A1
VEGF165
Plasma
Diabetic retinopathy
ELISA
title Plasma Ephrin-A1 level in a cohort of diabetic retinopathy patients
title_full Plasma Ephrin-A1 level in a cohort of diabetic retinopathy patients
title_fullStr Plasma Ephrin-A1 level in a cohort of diabetic retinopathy patients
title_full_unstemmed Plasma Ephrin-A1 level in a cohort of diabetic retinopathy patients
title_short Plasma Ephrin-A1 level in a cohort of diabetic retinopathy patients
title_sort plasma ephrin a1 level in a cohort of diabetic retinopathy patients
topic Ephrin-A1
VEGF165
Plasma
Diabetic retinopathy
ELISA
url http://link.springer.com/article/10.1186/s12886-020-01580-0
work_keys_str_mv AT dannamao plasmaephrina1levelinacohortofdiabeticretinopathypatients
AT yinghu plasmaephrina1levelinacohortofdiabeticretinopathypatients
AT qibao plasmaephrina1levelinacohortofdiabeticretinopathypatients
AT keweiwu plasmaephrina1levelinacohortofdiabeticretinopathypatients
AT yaodingzheng plasmaephrina1levelinacohortofdiabeticretinopathypatients
AT yukunyang plasmaephrina1levelinacohortofdiabeticretinopathypatients
AT bolei plasmaephrina1levelinacohortofdiabeticretinopathypatients
AT yingjiang plasmaephrina1levelinacohortofdiabeticretinopathypatients